Reported May 11, 2022 · Terminated

Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg a) 30-count bottles (NDC# 68180-215-06) b)…

Lupin Pharmaceuticals Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Lupin Pharmaceuticals Inc. · Harborplace Tower · Baltimore, MD · 21202-6174

Is this the product you have?

  • Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg a) 30-count bottles (NDC# 68180-215-06) b) 90-count bottles (NDC# 68180-215-09), Rx Only
  • Manufactured ByLupin Limited, Pithampur, India
  • MFG ForLupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA
Lot codes and dates
  • Lot #

    249 of 249 codes

    • H001149
    • 4/30/2022
    • 68180-215-06
    • H001602
    • 5/31/2022
    • 68180-215-06
    • H001884
    • 6/30/2022
    • 68180-215-06
    • H002539
    • 8/31/2022
    • 68180-215-06
    • H100944
    • 4/30/2023
    • 68180-215-06
    • H101054
    • 4/30/2023
    • 68180-215-06
    • H001150
    • 4/30/2022
    • 68180-215-09
    • H001151
    • 4/30/2022
    • 68180-215-09
    • H001152
    • 4/30/2022
    • 68180-215-09
    • H001532
    • 5/31/2022
    • 68180-215-09
    • H001533
    • 5/31/2022
    • 68180-215-09
    • H001534
    • 5/31/2022
    • 68180-215-09
    • H001535
    • 5/31/2022
    • 68180-215-09
    • H001536
    • 5/31/2022
    • 68180-215-09
    • H001603
    • 5/31/2022
    • 68180-215-09
    • H001604
    • 5/31/2022
    • 68180-215-09
    • H001605
    • 5/31/2022
    • 68180-215-09
    • H001606
    • 5/31/2022
    • 68180-215-09
    • H001607
    • 5/31/2022
    • 68180-215-09
    • H001608
    • 5/31/2022
    • 68180-215-09
Amount recalled
1,214,016 bottles

This recall covers 6 products

The agency filed one notice per product. You are reading one of them; the other 5 are below.

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Lupin Pharmaceuticals Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated May 22, 2023 · Data as of Sep 19, 7:59 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.